Telomeres and lung cancer incidence and survival

端粒与肺癌的发病率和生存率

基本信息

项目摘要

DESCRIPTION (provided by applicant): Lung cancer is the leading cause of cancer incidence and death worldwide. Once diagnosed with lung cancer, only 15% of individuals survive longer than five years. Tobacco-smoking is estimated to be responsible for 85- 90% of lung cancer cases, but fewer than 20% of smokers develop lung cancer, suggesting that other factors may play a predisposing role. Recently, several large-scale genome-wide association studies have reported that SNPs in the telomerase reverse transcriptase (TERT) gene are strongly associated with lung cancer risk. TERT is a telomere maintenance gene, and is often a site of chromosomal abnormalities in lung tumors. Telomeres, located at the ends of chromosomes, protect the genetic integrity of cells. They progressively shorten with every cell division, and after they reach a critically short length, the cell will undergo apoptosis or cellular senescence. Alternatively, critically short telomeres can cause chromosomal instability and fusions, allowing the accumulation of genetic changes in favor of carcinogenesis. While three case-control studies have observed that shorter telomere length was associated with lung cancer risk, longer telomere length (measured prior to lung cancer diagnosis) was associated with increased lung cancer risk in a nested case- control study. Given the discrepant but suggestive findings from these four studies, additional studies are needed to elucidate the role of telomere length in lung cancer development. It is possible that shortening of specific chromosomes is associated with an increased risk of lung cancer, though this has not been studied previously. Also, no studies to date have examined lymphocyte telomere length and lung cancer survival. In a nested case-control study (n=790 cases, 1,558 controls) within the Carotene and Retinol Efficacy Trial, a cohort of heavy smokers with blood samples collected prospectively, we propose to examine: whether global, and chromosome-arm-specific, telomere length measured in samples collected prior to lung cancer diagnosis are associated with lung cancer risk; whether approximately 400 tag and putative functional SNPs in TERT and other telomere maintenance-related genes are associated with lung cancer risk; and whether telomere length and variation in telomere maintenance genes are associated with survival among individuals who develop lung cancer. A large, prospective study among smokers such as the one proposed will provide evidence that will aid in clarifying whether telomere length is associated with lung cancer risk and/or survival. If either global or chromosome-specific telomere length is associated with lung cancer risk, this measurement could possibly be developed to identify a subset of individuals at particularly high risk of lung cancer, among the high-risk population of smokers.
描述(由申请人提供):肺癌是全球癌症发病率和死亡的主要原因。一旦被诊断为肺癌,只有15%的人能活过5年。据估计,85% - 90%的肺癌病例是由吸烟引起的,但只有不到20%的吸烟者患肺癌,这表明其他因素可能起着诱发作用。最近,一些大规模的全基因组关联研究报道了端粒酶逆转录酶(TERT)基因的snp与肺癌风险密切相关。TERT是端粒维持基因,常是肺肿瘤染色体异常的一个位点。端粒位于染色体的末端,保护细胞的遗传完整性。随着细胞的每一次分裂,它们逐渐缩短,当长度达到临界短时,细胞就会发生凋亡或细胞衰老。另外,极短的端粒会导致染色体不稳定和融合,从而导致有利于致癌的遗传变化的积累。三个病例对照研究发现,较短的端粒长度与肺癌风险相关,而较长的端粒长度(在肺癌诊断前测量)与肺癌风险增加有关。鉴于这四项研究的差异但具有启发性的发现,需要进一步的研究来阐明端粒长度在肺癌发展中的作用。特定染色体的缩短可能与肺癌风险的增加有关,尽管这在以前还没有被研究过。此外,到目前为止,还没有研究检测淋巴细胞端粒长度与肺癌生存率之间的关系。在胡萝卜素和视黄醇疗效试验中的巢式病例对照研究(n=790例,1558例对照)中,一组前瞻性采集血样的重度吸烟者,我们建议检查:肺癌诊断前采集样本中测量的整体和染色体臂特异性端粒长度是否与肺癌风险相关;TERT和其他端粒维持相关基因中大约400个标签和假定的功能snp是否与肺癌风险相关;以及端粒长度和端粒维持基因的变异是否与肺癌患者的生存有关。一项针对吸烟者的大型前瞻性研究将提供证据,有助于澄清端粒长度是否与肺癌风险和/或生存有关。如果整体端粒长度或染色体特异性端粒长度与肺癌风险相关,那么这种测量方法可能被用于识别高危吸烟者中肺癌风险特别高的个体亚群。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jennifer A. Doherty其他文献

Role of neighborhood context in ovarian cancer survival disparities: current research and future directions
邻里环境在卵巢癌生存差异中的作用:当前研究与未来方向
  • DOI:
    10.1016/j.ajog.2023.04.026
  • 发表时间:
    2023-10-01
  • 期刊:
  • 影响因子:
    8.400
  • 作者:
    Scarlett L. Gomez;Ekaterina Chirikova;Valerie McGuire;Lindsay J. Collin;Lauren Dempsey;Pushkar P. Inamdar;Katherine Lawson-Michod;Edward S. Peters;Lawrence H. Kushi;Juraj Kavecansky;Salma Shariff-Marco;Lauren C. Peres;Paul Terry;Elisa V. Bandera;Joellen M. Schildkraut;Jennifer A. Doherty;Andrew Lawson
  • 通讯作者:
    Andrew Lawson
Factors associated with cancer-related pain among Utah cancer survivors
犹他州癌症幸存者中与癌症相关疼痛相关的因素
  • DOI:
    10.1007/s11764-025-01840-2
  • 发表时间:
    2025-06-05
  • 期刊:
  • 影响因子:
    2.900
  • 作者:
    Rachel R. Codden;Blessing S. Ofori-Atta;Marjorie E. Carter;Kimberly A. Herget;Jennifer A. Doherty;Anne C. Kirchhoff;Morgan M. Millar
  • 通讯作者:
    Morgan M. Millar

Jennifer A. Doherty的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jennifer A. Doherty', 18)}}的其他基金

Characterization of high-grade serous ovarian cancer subtypes via single-cell profiling
通过单细胞分析表征高级别浆液性卵巢癌亚型
  • 批准号:
    10407165
  • 财政年份:
    2019
  • 资助金额:
    $ 52.89万
  • 项目类别:
Characterization of high-grade serous ovarian cancer subtypes via single-cell profiling
通过单细胞分析表征高级别浆液性卵巢癌亚型
  • 批准号:
    9883762
  • 财政年份:
    2019
  • 资助金额:
    $ 52.89万
  • 项目类别:
Characterization of high-grade serous ovarian cancer subtypes via single-cell profiling
通过单细胞分析表征高级别浆液性卵巢癌亚型
  • 批准号:
    10589920
  • 财政年份:
    2019
  • 资助金额:
    $ 52.89万
  • 项目类别:
Characterization of high-grade serous ovarian cancer subtypes via single-cell profiling
通过单细胞分析表征高级别浆液性卵巢癌亚型
  • 批准号:
    10438939
  • 财政年份:
    2019
  • 资助金额:
    $ 52.89万
  • 项目类别:
Characterizing Molecular Subtypes of Ovarian Cancer in African-American Women
非裔美国女性卵巢癌分子亚型特征
  • 批准号:
    9386358
  • 财政年份:
    2016
  • 资助金额:
    $ 52.89万
  • 项目类别:
Epidemiologic factors and survival by molecular subtypes of ovarian cancer
卵巢癌分子亚型的流行病学因素和生存率
  • 批准号:
    8631078
  • 财政年份:
    2013
  • 资助金额:
    $ 52.89万
  • 项目类别:
Epidemiologic factors and survival by molecular subtypes of ovarian cancer
卵巢癌分子亚型的流行病学因素和生存率
  • 批准号:
    9022436
  • 财政年份:
    2013
  • 资助金额:
    $ 52.89万
  • 项目类别:
Epidemiologic factors and survival by molecular subtypes of ovarian cancer
卵巢癌分子亚型的流行病学因素和生存率
  • 批准号:
    8504516
  • 财政年份:
    2013
  • 资助金额:
    $ 52.89万
  • 项目类别:
Telomeres and lung cancer incidence and survival
端粒与肺癌的发病率和生存率
  • 批准号:
    8107313
  • 财政年份:
    2011
  • 资助金额:
    $ 52.89万
  • 项目类别:
Telomeres and lung cancer incidence and survival
端粒与肺癌的发病率和生存率
  • 批准号:
    8316272
  • 财政年份:
    2011
  • 资助金额:
    $ 52.89万
  • 项目类别:

相似海外基金

SYNTHESIS AND BIOLOGICAL ACTIVITY OF A NEW ALL-TRANS-RETINOL METABOLITES
一种新的全反式视黄醇代谢物的合成和生物活性
  • 批准号:
    8361148
  • 财政年份:
    2011
  • 资助金额:
    $ 52.89万
  • 项目类别:
SYNTHESIS AND BIOLOGICAL ACTIVITY OF A NEW ALL-TRANS-RETINOL METABOLITES
一种新的全反式视黄醇代谢物的合成和生物活性
  • 批准号:
    8168931
  • 财政年份:
    2010
  • 资助金额:
    $ 52.89万
  • 项目类别:
SYNTHESIS AND BIOLOGICAL ACTIVITY OF A NEW ALL-TRANS-RETINOL METABOLITES
一种新的全反式视黄醇代谢物的合成和生物活性
  • 批准号:
    7954594
  • 财政年份:
    2009
  • 资助金额:
    $ 52.89万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了